company background image
5372

Sunil Healthcare BSE:537253 Stock Report

Last Price

₹110.05

Market Cap

₹1.1b

7D

8.9%

1Y

233.5%

Updated

17 Aug, 2022

Data

Company Financials
537253 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance4/6
Financial Health4/6
Dividends0/6

537253 Stock Overview

Sunil Healthcare Limited primarily manufactures and sells empty hard gelatin, hydroxypropyl methylcellulose (HPMC), and pullulan capsules shells in India.

Sunil Healthcare Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sunil Healthcare
Historical stock prices
Current Share Price₹110.05
52 Week High₹113.85
52 Week Low₹30.60
Beta0.58
1 Month Change53.17%
3 Month Change47.72%
1 Year Change233.49%
3 Year Change364.35%
5 Year Change39.48%
Change since IPO261.41%

Recent News & Updates

Shareholder Returns

537253IN PharmaceuticalsIN Market
7D8.9%1.0%2.7%
1Y233.5%-11.3%9.8%

Return vs Industry: 537253 exceeded the Indian Pharmaceuticals industry which returned -11.7% over the past year.

Return vs Market: 537253 exceeded the Indian Market which returned 9.1% over the past year.

Price Volatility

Is 537253's price volatile compared to industry and market?
537253 volatility
537253 Average Weekly Movement8.3%
Pharmaceuticals Industry Average Movement5.9%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market4.1%

Stable Share Price: 537253 is more volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: 537253's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.

About the Company

FoundedEmployeesCEOWebsite
1973225Anil Khaitanhttps://www.sunilhealthcare.com

Sunil Healthcare Limited primarily manufactures and sells empty hard gelatin, hydroxypropyl methylcellulose (HPMC), and pullulan capsules shells in India. Its products include EHG, BSE/TSE free, pearl, liquid fill, preservative free, stick free, flavored, SLS free, natural color, non-AZO, HPMC/vegetable, and pullulan capsules. The company also provides ayurvedic products.

Sunil Healthcare Fundamentals Summary

How do Sunil Healthcare's earnings and revenue compare to its market cap?
537253 fundamental statistics
Market Cap₹1.13b
Earnings (TTM)₹103.97m
Revenue (TTM)₹1.26b

10.9x

P/E Ratio

0.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
537253 income statement (TTM)
Revenue₹1.26b
Cost of Revenue₹482.11m
Gross Profit₹778.00m
Other Expenses₹674.03m
Earnings₹103.97m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)10.14
Gross Margin61.74%
Net Profit Margin8.25%
Debt/Equity Ratio69.4%

How did 537253 perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is 537253 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 537253?

Other financial metrics that can be useful for relative valuation.

537253 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.1x
Enterprise Value/EBITDA6.5x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does 537253's PE Ratio compare to its peers?

537253 PE Ratio vs Peers
The above table shows the PE ratio for 537253 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average16.4x
506128 Parnax Lab
12.4xn/a₹1.1b
524412 Aarey Drugs & Pharmaceuticals
13.7xn/a₹896.1m
524202 Lactose (India)
30.2xn/a₹965.6m
ALPA Alpa Laboratories
9.2xn/a₹1.3b
537253 Sunil Healthcare
10.9xn/a₹1.1b

Price-To-Earnings vs Peers: 537253 is good value based on its Price-To-Earnings Ratio (10.9x) compared to the peer average (16.4x).


Price to Earnings Ratio vs Industry

How does 537253's PE Ratio compare vs other companies in the IN Pharmaceuticals Industry?

Price-To-Earnings vs Industry: 537253 is good value based on its Price-To-Earnings Ratio (10.9x) compared to the Indian Pharmaceuticals industry average (22.5x)


Price to Earnings Ratio vs Fair Ratio

What is 537253's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

537253 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio10.9x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 537253's Price-To-Earnings Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of 537253 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 537253 (₹110.05) is trading below our estimate of fair value (₹348.4)

Significantly Below Fair Value: 537253 is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies

Future Growth

How is Sunil Healthcare forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


19.2%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sunil Healthcare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Discover growth companies

  • Examine whether Sunil Healthcare is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
  • Sunil Healthcare competitive advantages and company strategy can generally be found in its financial reports archived here.

Past Performance

How has Sunil Healthcare performed over the past 5 years?

Past Performance Score

4/6

Past Performance Score 4/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


53.7%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 537253 has high quality earnings.

Growing Profit Margin: 537253 became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: 537253's earnings have grown significantly by 53.7% per year over the past 5 years.

Accelerating Growth: 537253 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 537253 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-0.3%).


Return on Equity

High ROE: 537253's Return on Equity (20.8%) is considered high.


Discover strong past performing companies

Financial Health

How is Sunil Healthcare's financial position?

Financial Health Score

4/6

Financial Health Score 4/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 537253's short term assets (₹348.1M) do not cover its short term liabilities (₹398.1M).

Long Term Liabilities: 537253's short term assets (₹348.1M) exceed its long term liabilities (₹199.2M).


Debt to Equity History and Analysis

Debt Level: 537253's net debt to equity ratio (62.5%) is considered high.

Reducing Debt: 537253's debt to equity ratio has reduced from 110.3% to 69.4% over the past 5 years.

Debt Coverage: 537253's debt is well covered by operating cash flow (64.9%).

Interest Coverage: 537253's interest payments on its debt are well covered by EBIT (4.8x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is Sunil Healthcare current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate 537253's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 537253's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 537253's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 537253's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as 537253 has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

9.3yrs

Average management tenure


CEO

Anil Khaitan (66 yo)

3yrs

Tenure

₹2,998,427

Compensation

Mr. Anil Kumar Khaitan has been Chief Executive Officer of Sunil Healthcare Ltd since August 14, 2019. He has been the Chairman of the Board at Sunil Healthcare Ltd. since August 1, 2007 and serves as its...


CEO Compensation Analysis

Compensation vs Market: Anil's total compensation ($USD37.80K) is about average for companies of similar size in the Indian market ($USD37.73K).

Compensation vs Earnings: Anil's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: 537253's management team is seasoned and experienced (9.3 years average tenure).


Board Members

Experienced Board: 537253's board of directors are considered experienced (3.5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Sunil Healthcare Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Sunil Healthcare Limited
  • Ticker: 537253
  • Exchange: BSE
  • Founded: 1973
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: ₹1.129b
  • Shares outstanding: 10.25m
  • Website: https://www.sunilhealthcare.com

Number of Employees


Location

  • Sunil Healthcare Limited
  • 38E/252-A, Vijay Tower
  • Shahpur Jat
  • New Delhi
  • Delhi
  • 110049
  • India

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/08/17 00:00
End of Day Share Price2022/08/17 00:00
Earnings2022/06/30
Annual Earnings2022/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.